Term
|
Definition
| Ultra Short Acting Insulin |
|
|
Term
|
Definition
| Ultra Short Acting Insulin |
|
|
Term
|
Definition
| Ultra Short Acting Insulin |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Intermediate Acting Insulin |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
Synthetic Amyline
Facilitates Insulin
*Hypoglycemia, SC |
|
|
Term
|
Definition
Insulin Sensitizer
Biguanide
AMPK
*Contraindications in GI, Kidney, Liver, Lung dz |
|
|
Term
|
Definition
TZD Insulin Sensitizer
*Risk for CAD, MI, Stroke
NOT for CHF
PPAR-y gene |
|
|
Term
|
Definition
TZD Insulin Sensitizer
NOT for CHF
PPAR-y gene |
|
|
Term
|
Definition
Insulin Secretagogue
2nd gen Sulfonlyurea
*Hypoglycemia, Teratogenic
BID |
|
|
Term
|
Definition
Insulin Secretagogue
2nd gen sulfonylurea
*Hypoglycemia, Teragtogenic
BID |
|
|
Term
|
Definition
Insulin Secretagogue
3rd Gen sulfonylurea
*Lowest Hypoglycemia risk, teratogenic
QD |
|
|
Term
|
Definition
Meglitinide Insulin Secretagogue
hypoglycemia
short acting, take before meals |
|
|
Term
|
Definition
Meglitinide Insulin Secretagogue
*hypoglycemia
short acting, take before meals |
|
|
Term
|
Definition
Incretin GLP-1 agonist
inject BID |
|
|
Term
|
Definition
Incretin GLP-1 agonist
QD injections |
|
|
Term
|
Definition
Incretin DPP-4 inhibitor
*WL, decreased hypoglycemia
oral, $$ |
|
|
Term
|
Definition
Incretin DPP-4 inhibitor
*WL, decreased hypoglycemia
oral, $$ |
|
|
Term
|
Definition
Incretin DPP-4 inhibitor
*WL, decreased hypoglycemia
oral, $$ |
|
|
Term
|
Definition
a-glucosidase inhibitor
*GI side effects
requires glucose tab |
|
|
Term
|
Definition
a-glucosidase inhibitor
*GI side effects
requires glucose tab |
|
|
Term
|
Definition
Class 1a antiarrhythmic
Anticholinergic, K channel blocker
*Torsades |
|
|
Term
|
Definition
Class 1a antiarhythmic
anticholinergic, k channel blocker
*torsades |
|
|
Term
|
Definition
Class 1b antiarrhythmic
no k+ channel block
*emergency use |
|
|
Term
|
Definition
Class 1b antiarrhythmic
no k channel block
*emergency use |
|
|
Term
|
Definition
Class 1c antiarrhythmic
no k channel block
slower acting than class b |
|
|
Term
|
Definition
Class III antiarrhythmic
*Torsades |
|
|
Term
|
Definition
Class III antiarrhythmic
Mixed action (1, 2, 3, 4)
*Adverse effects |
|
|
Term
|
Definition
Class III antiarrhythmic
Mixed action (2,3)
Beta and K blocker |
|
|
Term
|
Definition
Class II antiarrhythmic
Cardioselective B blocker |
|
|
Term
|
Definition
Class II antiarrhythmic
Noncardioselective B blocker |
|
|
Term
|
Definition
Class IV antiarrhythmic
Cardioactive CCB |
|
|
Term
|
Definition
Class IV antiarrhythmic
Cardioactive CCB |
|
|
Term
|
Definition
Short acting Amide anesthetic
most common in dentistry |
|
|
Term
|
Definition
Intermediate acting amide anesthetic
Doesn't require vasoconstrictor
lowest pka |
|
|
Term
|
Definition
Short acting amide anesthetic
Doesnt require vasoconstrictor
*Methemeglobin=impaired o2 transport |
|
|
Term
|
Definition
Long acting amide anesthetic
can be used for epidural, but more cardiotoxic |
|
|
Term
|
Definition
| Intermediate acting amide anesthetic |
|
|
Term
|
Definition
Long acting amide anesthetic
Pregnancy epidural |
|
|
Term
|
Definition
Ester anesthetic
vasoconstrictor |
|
|
Term
|
Definition
Ester anesthetic
Longest onset, pka 9.1 |
|
|
Term
|
Definition
Topical anesthetic ester
for itching and pain |
|
|
Term
|
Definition
Topical anesthetic ester
for itching and pain
numbing gel for injections |
|
|
Term
|
Definition
| Ester Anesthetic Eyedrops |
|
|
Term
|
Definition
a1 agonist vasoconstrictor
*DO NOT use for digital injuries
*Avoid with CAD, HTN, MAOIs or other a1 agonists |
|
|
Term
|
Definition
| a1 agonist vasoconstrictor |
|
|
Term
|
Definition
| Topical anesthetic for pain and itching |
|
|
Term
|
Definition
| Topical anesthetic for pain and itching |
|
|
Term
|
Definition
| Anesthetic for Lacerations |
|
|
Term
|
Definition
| Anesthetic for lacerations |
|
|
Term
|
Definition
Mineralcordicoid
salt retention |
|
|
Term
|
Definition
Synthetic mineralcorticoid
Addisons |
|
|
Term
| Deoxycorticosterone Acetate |
|
Definition
|
|
Term
|
Definition
| Short acting, nonselective corticoid |
|
|
Term
|
Definition
Synthetic Short acting, nonselective corticoid
Addisons
IIB-HydroxySteroid Dehydrogenase doesnt work |
|
|
Term
|
Definition
Short acting glucocorticoid
antiinflammatory |
|
|
Term
|
Definition
Short acting glucocorticoid
antiinflammatory |
|
|
Term
|
Definition
Intermediate acting glucocorticoid
antinflammatory |
|
|
Term
|
Definition
Long acting glucocorticoid
Antiinflammatory
Cushings |
|
|
Term
|
Definition
Long acting glucocorticoid
anti inflammatory |
|
|
Term
|
Definition
Glucocorticoid Synthesis Inhibitor
cushings |
|
|
Term
|
Definition
RU486- Glucocorticoid Receptor Antagonist
*Terminates Pregnancy |
|
|
Term
|
Definition
MR receptor antagonist
spares K+ |
|
|
Term
|
Definition
| Newer MR receptor antagonist |
|
|
Term
|
Definition
Alkylating chemo agent
Phase nonspecific
*Carcinogenic |
|
|
Term
|
Definition
Antitumor antibody chemo drug
Block topoisomerase II
phase nonspecific (g2) |
|
|
Term
|
Definition
Antitumor antibody chemo drug
chelates Fe-->DNA breaks
phase nonspecific *Pulmonary Fibrosis |
|
|
Term
|
Definition
Microtubule inhibitor chemo drug
Vinca alkyloid
prevents spindle formation |
|
|
Term
|
Definition
DNA synthesis inhibitor chemo drug
Purine/Pyrimidine Analogue
S phase specific |
|
|
Term
|
Definition
DNA synthesis inhibitor chemo drug
Folate analogue-->prevents purine sythesis
S phase specific |
|
|
Term
|
Definition
| Rescues cells from high dose Methotrexate |
|
|
Term
|
Definition
DNA synthesis inhibitor chemo drug
Topoisomerase inhibitor |
|
|
Term
|
Definition
| Anti-angiogenic--> inhibit tumor BV growth |
|
|
Term
|
Definition
Chemo- Selective Estrogen Receptor Modulator (SERM)
Treat/Prevent ER(+) breast CA
*Cytostatic *Endometrial CA risk |
|
|
Term
|
Definition
|
|
Term
|
Definition
CML chemo drug
Kinase inhibitor targets oncogene products |
|
|
Term
|
Definition
|
|
Term
|
Definition
Longer acting b2 agonist controller
used prohylactically
not for monotherapy |
|
|
Term
|
Definition
Inhaled Controller glucocorticoid
Reduce frequency and severity of asthma exacerbations |
|
|
Term
|
Definition
Systemic Reliever glucocorticoid
For acute asthma attack and chronic severe asthma
*Adverse effects past 2weeks |
|
|
Term
|
Definition
Leukotriene Synthesis inhibitor
oral controller
Severe or *NSAID induced asthma |
|
|
Term
|
Definition
Leukotriene receptor antagonist
Severe or *NSAID induced asthma |
|
|
Term
|
Definition
Adenosine Receptor antagonist-->bronchodilation
Oral overnight controller of mod-severe asthma |
|
|
Term
|
Definition
Anti IgE asthma controller
*Does not reduce acute bronchospasm |
|
|
Term
|
Definition
Mast Cell stabilizer, qid
Mild, Persistent, or *exercise induced asthma
*Will not reduce acute bronchospasm |
|
|
Term
|
Definition
Antimuscarinic-->Parasympatholytic Asthma Reliever
Used when B agonists are contraindicated
(MAOI, Arrhythmia) |
|
|
Term
|
Definition
Proton Pump Inibitor
Used also with ABx for H pylori
*Inhibits CYP450 2C19(Diazepam) |
|
|
Term
|
Definition
|
|
Term
|
Definition
Histamine Receptor Antagonist
*CYP450 interactions with Warfarin and Theophyllin |
|
|
Term
|
Definition
Histamine Receptor Antagonist
(pepsid) |
|
|
Term
|
Definition
Prostaglandin analogue
For NSAID damage
*NOT for pregnant women..abortions |
|
|
Term
|
Definition
Antihistamine for Vestibular Nausea
Block H1 receptor
(dramamine) |
|
|
Term
|
Definition
Anticholinergic for Vestibular Nausea
Inhibits muscarinic receptors |
|
|
Term
|
Definition
Dopamine receptor antagonist for visceral nausea
*Parkinson symptoms |
|
|
Term
|
Definition
Dopamine receptor antagonist for visceral nausea
*Parkinson symptoms |
|
|
Term
|
Definition
Serotonin receptor antagonist for visceral nausea
reduce colonic motility and emetic signals |
|
|
Term
|
Definition
Tobacco Addiction
Nicotinic receptor partial agonist |
|
|
Term
|
Definition
Tobacco Addiction
Antidepressant
Increase NE and DA |
|
|
Term
|
Definition
Heroin addiction
m opiod receptor antagonist
*Reverse Heroin OD! *Hepatotoxic! |
|
|
Term
|
Definition
Heroin
m opiod receptor agonist
transfers dependence, prevents withdrawal |
|
|
Term
|
Definition
Heroin addiction
stimulate a2 receptor
masks withdrawal effects |
|
|
Term
|
Definition
Alcohol withdrawal
Long acting sedative (GABA) |
|
|
Term
|
Definition
Alcohol withdrawal
antiseizure--> increase Na channel inactivation |
|
|
Term
|
Definition
Alcohol Relapse
Cause N/V by blocking acetylaldehyde dehydrogenase
*Hepatoxic *DO NOT USE with NALTREXONE |
|
|
